🎯 check Brigimadlin product page
Brigimadlin is a potent MDM2 antagonist. It affects p53 signaling by upregulating p53, inhibiting tumor cell viability.
Brigimadlin MOA:Targeting MDM2/p53 Pathway for Dedifferentiated Liposarcoma
🎯 check Brigimadlin product page
Brigimadlin is a potent MDM2 antagonist. It affects p53 signaling by upregulating p53, inhibiting tumor cell viability.